Aesthetic Medical International Holdings Group Ltd

Aesthetic Medical International Holdings Group Ltd(AIH)財務資料

AIH 營收結構

Aesthetic Medical International Holdings Group Ltd (AIH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-surgical aesthetic medical services, accounting for 60.4% of total sales, equivalent to CNY 143.67M. Other significant revenue streams include Surgical aesthetic medical services and General healthcare services and other aesthetic medical services. Understanding this composition is critical for investors evaluating how AIH navigates market cycles within the Healthcare Facilities & Services industry.

AIH 獲利能力與利潤率

Evaluating the bottom line, Aesthetic Medical International Holdings Group Ltd maintains a gross margin of 43.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -4.28%, while the net margin is -6.17%. These profitability ratios, combined with a Return on Equity (ROE) of -131.31%, provide a clear picture of how effectively AIH converts its operational activities into shareholder value.

Financials

FY2023Q2
YoY:
-4.20%
170.42M
Total Revenue
FY2023Q2
YoY:
-301.43%
-13.49M
Operating Profit
FY2023Q2
YoY:
+951.32%
-11.53M
Net Income after Tax
FY2023Q2
YoY:
+300.00%
-0.08
EPS - Diluted
FY2024Q2
YoY:
-5.43%
43.90
Gross Profit Margin - %
FY2024Q2
YoY:
-8.86%
-6.17
Net Margin - %

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始